202 related articles for article (PubMed ID: 2401172)
1. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
Yu H
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
[TBL] [Abstract][Full Text] [Related]
2. [The screening model for early diagnosis of colorectal cancer in general population].
Zheng S
Zhonghua Yi Xue Za Zhi; 1991 Jul; 71(7):381-4, 28. PubMed ID: 1659480
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
4. [Mass screening for colorectal cancer by occult blood testing under restricted diet].
Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
Gan No Rinsho; 1984 Jul; 30(8):925-32. PubMed ID: 6471396
[TBL] [Abstract][Full Text] [Related]
5. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
Chen K
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
[TBL] [Abstract][Full Text] [Related]
6. [Occult blood screening for colorectal cancer].
Kumanishi Y; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
[TBL] [Abstract][Full Text] [Related]
7. Results of screening for colorectal cancer.
Crespi M; Casale V; Grassi A; Caperle M; Casale G; Conti E
Endoscopy; 1981 Sep; 13(5):203-6. PubMed ID: 7274170
[TBL] [Abstract][Full Text] [Related]
8. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
9. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
Li S; Zhang C; Xu E
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening: new opportunities.
Levin TR
Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
[TBL] [Abstract][Full Text] [Related]
15. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
16. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
[TBL] [Abstract][Full Text] [Related]
17. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
18. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
[TBL] [Abstract][Full Text] [Related]
20. Occult-blood screening for colorectal carcinoma: the risks.
Frank JW
Am J Prev Med; 1985; 1(4):25-32. PubMed ID: 3870908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]